Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages

Abstract

Epigenetic modification, including histone modification, precisely controls target gene expression. The posttranscriptional regulation of the innate signaling-triggered production of inflammatory cytokines and type I interferons has been fully elucidated, whereas the roles of histone modification alteration and epigenetic modifiers in regulating inflammatory responses need to be further explored. Di/tri-methylation modifications of histone 3 lysine 79 (H3K79me2/3) have been shown to be associated with gene transcriptional activation. Disruptor of telomeric silencing-1-like (Dot1l) is the only known exclusive H3K79 methyltransferase and regulates the proliferation and differentiation of tumor cells. However, the roles of Dot1l and Dot1l-mediated H3K79 methylation in innate immunity and inflammatory responses remain unclear. Here, we found that H3K79me2/3 modification levels at the Il6 and Ifnb1 promoters, as well as H3K79me2 modification at the Tnfα promoter, were increased in macrophages activated by Toll-like receptor (TLR) ligands or virus infection. The innate signals upregulated Dot1l expression in macrophages and THP1 cells. Dot1l silencing or a Dot1l inhibitor preferentially suppressed the production of IL-6 and interferon (IFN)-β but not of TNF-α in macrophages and THP1 cells triggered by TLR ligands or virus infection. Dot1l was recruited to the proximal promoter of the Il6 and Ifnb1 but not Tnfα gene and then mediated H3K79me2/3 modification at the Il6 and Ifnb1 promoters, consequently facilitating the transcription and expression of Il6 and Ifnb1. Thus, Dot1l-mediated selective H3K79me2/3 modifications at the Il6 and Ifnb1 promoters are required for the full activation of innate immune responses. This finding adds new insights into the epigenetic regulation of inflammatory responses and pathogenesis of autoimmune diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kieser, K. J. & Kagan, J. C. Multi-receptor detection of individual bacterial products by the innate immune system. Nat. Rev. Immunol. 17, 376–390 (2017).

    Article  CAS  Google Scholar 

  2. Lee, M. S. & Kim, Y. J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447–480 (2007).

    Article  CAS  Google Scholar 

  3. Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855–869 (2013).

    Article  CAS  Google Scholar 

  4. Takeuchi, O. & Akira, S. Pattern-recognition receptors and inflammation. Cell 140, 805–820 (2010).

    Article  CAS  Google Scholar 

  5. Cao, X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat. Rev. Immunol. 16, 35–50 (2016).

    Article  CAS  Google Scholar 

  6. Liu, X. et al. MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production. Cell Mol Immunol. 15, 99–110 (2018).

    Article  CAS  Google Scholar 

  7. Chiang, C. & Gack, M. U. Post-translational control of intracellular pathogen sensing pathways. Trends Immunol. 38, 39–52 (2017).

    Article  CAS  Google Scholar 

  8. Zhang H., Han C., Li T., Li N., Cao X. The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling. Cell Mol Immunol. 2018; in press.

  9. Zhong, Q. et al. IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in rheumatoid arthritis. J. Immunol. 200, 3913–3925 (2018).

    Article  CAS  Google Scholar 

  10. Sayed, N. et al. Retinoic acid inducible gene 1 protein (RIG1)-like receptor pathway is required for efficient nuclear reprogramming. Stem Cells 35, 1197–1207 (2017).

    Article  CAS  Google Scholar 

  11. Grazioli, E. et al. Physical activity in the prevention of human diseases: role of epigenetic modifications. BMC Genomics 18, 802 (2017).

    Article  Google Scholar 

  12. Greer, E. L. & Shi, Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343–357 (2012).

    Article  CAS  Google Scholar 

  13. Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389–393 (2015).

    Article  CAS  Google Scholar 

  14. Black, J. C., Van Rechem, C. & Whetstine, J. R. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell 48, 491–507 (2012).

    Article  CAS  Google Scholar 

  15. Xia, M. et al. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39, 470–481 (2013).

    Article  CAS  Google Scholar 

  16. Liu, Y. et al. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip. J. Immunol. 194, 2838–2846 (2015).

    Article  CAS  Google Scholar 

  17. Li, X. et al. Demethylase Kdm6a epigenetically promotes IL-6 and IFN-β production in macrophages. J. Autoimmun. 80, 85–94 (2017).

    Article  CAS  Google Scholar 

  18. Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404–408 (2012).

    Article  CAS  Google Scholar 

  19. Schliehe, C. et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat. Immunol. 16, 67–74 (2015).

    Article  CAS  Google Scholar 

  20. McLean, C. M., Karemaker, I. D. & van Leeuwen, F. The emerging roles of Dot1l in leukemia and normal development. Leukemia 28, 2131–2138 (2014).

    Article  CAS  Google Scholar 

  21. Farooq, Z., Banday, S., Pandita, T. K. & Altaf, M. The many faces of histone H3K79 methylation. Mutat. Res. Rev. Mutat. Res 768, 46–52 (2016).

    Article  CAS  Google Scholar 

  22. Bernt, K. M. et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell. 20, 66–78 (2011).

    Article  CAS  Google Scholar 

  23. Wong, M. et al. The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription. Cancer Res. 77, 2522–2533 (2017).

    Article  CAS  Google Scholar 

  24. Gao, Y. & Ge, W. The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis. Cell Death Dis. 9, 33 (2018).

    Article  Google Scholar 

  25. Castaño Betancourt, M. C. et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc. Natl Acad. Sci. USA 109, 8218–8223 (2012).

    Article  Google Scholar 

  26. Shen, Q. et al. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature 554, 123–127 (2018).

    Article  CAS  Google Scholar 

  27. Schübeler, D. et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18, 1263–1271 (2004).

    Article  Google Scholar 

  28. Pokholok, D. K. et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122, 517–527 (2005).

    Article  CAS  Google Scholar 

  29. Vakoc, C. R., Sachdeva, M. M., Wang, H. & Blobel, G. A. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell Biol. 26, 9185–9195 (2006).

    Article  CAS  Google Scholar 

  30. Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521–533 (2008).

    Article  CAS  Google Scholar 

  31. Cho, M. H. et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat. Commun. 6, 7821 (2015).

    Article  CAS  Google Scholar 

  32. Feinberg, A. P. Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433–440 (2007).

    Article  CAS  Google Scholar 

  33. Nishina, N. et al. Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy. Ann. Rheum. Dis. 73, 945–947 (2014).

    Article  Google Scholar 

  34. Fiedler SE, et al. Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs. J. Syst. Integr. Neurosci. 2017; 3. https://doi.org/10.15761/JSIN.1000166.

  35. Hagberg, N. & Rönnblom, L. Systemic lupus erythematosus-a disease with A dysregulated type I interferon system. Scand. J. Immunol. 82, 199–207 (2015).

    Article  CAS  Google Scholar 

  36. Theofilopoulos, A. N., Baccala, R., Beutler, B. & Kono, D. H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307–336 (2005).

    Article  CAS  Google Scholar 

  37. Aslani, S. et al. Epigenetic alterations underlying autoimmune diseases. Autoimmunity 49, 69–83 (2016).

    Article  CAS  Google Scholar 

  38. Yarilina, A., Park-Min, K. H., Antoniv, T., Hu, X. & Ivashkiv, L. B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378–387 (2008).

    Article  CAS  Google Scholar 

  39. Menssen, A. et al. SiPaGene: a new repository for instant online retrieval, sharing and meta-analyses of Gene ChIP expression data. BMC Genomics 10, 98 (2009).

    Article  Google Scholar 

Download references

Acknowledgements

We thank Mrs X. Sun and M. Jin for technical assistance. This work was supported by the National Natural Science Foundation of China (81788101, 31570871, 31770970), CAMS Innovation Fund for Medical Sciences (2016-12M-1-003) and the National Key Basic Research Program of China (2015CB964403).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xuetao Cao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, X., Liu, X., Zhang, Y. et al. Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages. Cell Mol Immunol 17, 76–84 (2020). https://doi.org/10.1038/s41423-018-0170-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-018-0170-4

Key words

This article is cited by

Search

Quick links